CDC Advisory Panel To Discuss Vaccine Safety, Guillain-Barré Syndrome
The announcement came a day after federal regulators added a warning to Johnson & Johnson's covid vaccine about a link to the rare syndrome. Other reports say the CDC is also "keenly interested" in whether vaccine boosters have a higher risk of side effects.